Healthtech & Wellness VC Funds

Endure Capital, founded in 2015 by Tarek Fahim, is an early-stage investment fund based in Cairo, Egypt. The firm focuses on investing in startups across various sectors, including technology, healthcare, fintech, and foodtech. With an asset under management (AUM) of $85 million, Endure Capital has invested in 52 companies and has had significant exits, including Careem, which was acquired by Uber for $3.1 billion. The firm's notable investments include regional leaders like MaxAB, a B2B e-commerce platform, and Breadfast, a pioneering grocery delivery startup. Internationally, their portfolio features companies like Boom Supersonic and Aspect Biosystems. Endure Capital typically invests in pre-seed, seed, Series A, and Series B rounds, with ticket sizes ranging from $1 million to $5 million. Endure Capital recently closed the first round of its $50 million fund, Endure 21, aimed at impact-driven early-stage startups in Africa and selectively investing in growth-stage startups globally. The firm is expanding its reach into North America and Saudi Arabia, launching the Arak Fund in partnership with Awaed Capital, which focuses on various advanced sectors including space technology and AI infrastructure. Endure Capital also emphasizes long-term support and mentorship for its portfolio companies through initiatives like “Endure... Pay it Forward,” reflecting its commitment to nurturing a vibrant startup ecosystem.

Energy Impact Partners (EIP) is a New York-based venture capital firm, established in 2015, with over $2 billion in assets under management. EIP specializes in investments that drive the global transition to sustainable energy, targeting sectors like ClimateTech, energy storage, smart grids, and mobility. Their notable portfolio companies include GridX, Grover, Hippo Harvest, and Innowatts​. EIP’s investment strategy focuses on collaborating with leading energy and industrial companies to accelerate the adoption of clean energy technologies. They typically invest in early to growth-stage companies, with a preference for those showing strong potential in transforming the energy landscape. Their investments range broadly but are particularly concentrated in North America and Europe​. The firm has closed over 100 investments and boasts significant exits, demonstrating a strong track record in identifying and nurturing high-impact startups. EIP’s team, comprising nearly 60 professionals, operates from offices in major cities including San Francisco, Palm Beach, London, Cologne, and Oslo​​. For startups aiming to engage with EIP, it’s crucial to present innovative solutions that align with their mission of fostering sustainable energy advancements. Networking through industry events and leveraging introductions from their extensive corporate partner network can be effective ways to approach them.

Engineering Capital, founded in 2015 by Ashmeet Sidana, is a venture capital firm based in Mountain View, California. The firm focuses on seed-stage investments in technology companies, particularly in information technology, cybersecurity, and SaaS sectors. Engineering Capital partners with technical entrepreneurs to support innovative ideas and help shape the future of technology. The firm has a notable portfolio with investments in companies such as YotaScale, Baffle, and Airgap Networks. Engineering Capital is known for being one of the first investors in these companies, often leading and anchoring their seed rounds. The firm has had several successful exits, including Rubrik's IPO and acquisitions of companies like Cortex Labs and Nimbella. Engineering Capital's investment approach is unique due to Ashmeet Sidana's deep technical expertise and hands-on involvement. Sidana is renowned for his ability to provide practical wisdom and support to startups, helping them navigate the challenges of achieving product-market fit and scaling their operations. This approach has fostered long-term relationships with multiple successful CEOs, who often choose to work with Engineering Capital again for their subsequent ventures. Overall, Engineering Capital distinguishes itself by investing early in technically insightful projects and maintaining a strong focus on long-term collaboration and support for its portfolio companies​.

Eniac Ventures is a premier seed-stage venture capital firm with a notable portfolio including Hinge, Headspace, and Tapad. Focused on AI, SaaS, healthcare, and deep tech, Eniac invests primarily in U.S.-based companies. The firm typically leads seed rounds with average check sizes ranging from $500K to $1M, and is renowned for its hands-on approach and strategic support. Co-founders Hadley Harris and Nihal Mehta leverage their extensive entrepreneurial backgrounds to guide startups towards success. Eniac prefers pitches that demonstrate strong technical foundations and significant market potential. They have been especially active recently, seeking bold, transformative startups that can redefine their industries. For founders, a warm introduction and a well-prepared, concise pitch are key to gaining their attention. Eniac’s team is dedicated to fostering innovation and driving growth, positioning themselves as valuable partners in the startup ecosystem.

EnjoyVenture GmbH is a Dusseldorf-based venture capital firm founded in 2000 with a focus on life sciences and technology. The firm manages approximately €160 million across its third generation of funds and has invested in more than 200 startups since founding, making it one of Germany's most prolific seed investors. EnjoyVenture leads rounds and backs companies at Pre-seed and Seed stages with checks typically in the $100,000 to $2 million range. The portfolio of 200 investments spans software, healthtech, biotech, AI and deep tech, SaaS, e-commerce, hardware, data analytics, and clean technology. The firm's portfolio includes one unicorn, Grover, a device-as-a-service platform, and 9 acquisitions including GridScale and VoiceObjects. EnjoyVenture's interdisciplinary investment team consists of 13 business professionals, 5 industrial engineers, and 1 lawyer, giving it an unusually broad set of domain capabilities across both technology and life sciences sectors. EnjoyVenture operates with topic and region-specific investment criteria across its seed fund products, allowing it to match capital and expertise to particular verticals. The firm primarily focuses on German and broader European startups, with a track record built over 25 years of backing early-stage founders across diverse technology sectors. The combination of deep life sciences knowledge and broad technology investment experience positions EnjoyVenture as a generalist seed champion within the German-speaking venture landscape.

Enso Ventures is a private investment firm founded in 2010, with offices in London and New York. The firm focuses on selective equity investments in high-technology and biotechnology companies, particularly in Europe and the United States. Enso Ventures leverages its industry expertise and capital to accelerate the commercial development of startup companies in fields like materials technology and life sciences. Enso Ventures typically participates in Series A rounds and later, with an average round size of around $6 million. The firm has built a portfolio of 15 companies, with 7 successful exits to date. Notable investments include companies like Cavion, which focuses on innovative pharmaceutical solutions, NeuroVia, specializing in drug discovery, and Seres Therapeutics, a leader in biotechnology. Enso Ventures aims to back startups that are poised to drive significant advancements in their industries, with a focus on developing disruptive technologies in both the biotech and materials tech sectors.

Enterprise Equity Venture Capital (EEVC) is a prominent venture capital firm based in Ireland, focusing on early-stage high-growth technology businesses. The firm has been instrumental in the growth of several notable companies by providing not only financial support but also strategic guidance and corporate governance. Key investments include Phorest, a leading SaaS platform for the salon industry; Duolog, a technology company; SensL, a developer of innovative sensing solutions; and StoryToys, an interactive entertainment company. These investments highlight EEVC's commitment to fostering innovation and supporting companies from their initial stages through to significant growth phases. The team at EEVC, including Managing Partner Conor O'Connor and Partners Tom Shinkwin and Frank Walsh, brings extensive operational expertise and domain knowledge. This experience allows them to provide valuable insights and support to their portfolio companies, ensuring they navigate the challenges of scaling a business effectively. EEVC also manages the AIB Seed Capital Fund, a €53 million fund dedicated to investing in start-ups and early-stage companies with high growth potential based in Ireland. This fund further underscores EEVC's role in nurturing innovation within the technology sector​.

Enterprise Ventures Limited was a UK-based venture capital firm founded in 1982 in Preston, England, one of the earliest regional venture investors in the country. The firm specialized in seed and early-stage investments, growth financing, and management buy-out and buy-in transactions for small and medium-sized enterprises across England and Wales. Enterprise Ventures led rounds with checks ranging from $100,000 to $5 million at Seed, Series A, and Series B stages, building a portfolio of approximately 150 equity investments in innovative companies across a wide range of sectors. The firm's portfolio spanned software, healthtech, hardware and robotics, AI and deep technology, business services, e-commerce, clean technology, data analytics, fintech, and education, primarily serving companies in northern England with early-stage institutional capital at a time when such support was scarce outside London. Enterprise Ventures managed third-party funds and operated as the primary provider of early-stage finance to regional SMEs in its geography for over three decades. In March 2016, Enterprise Ventures was acquired by Mercia Technologies, now Mercia Asset Management, a UK-listed investment group that continued the regional early-stage investment mandate on a larger scale. The acquisition gave Mercia an established portfolio, regional relationships, and an experienced team with roots in the northern England startup ecosystem. Enterprise Ventures is no longer independently active but its legacy is embedded in Mercia's broader regional venture strategy.

Entrada Ventures is an early-stage venture capital firm based in California, with offices in Santa Barbara and Silicon Valley. The firm primarily focuses on investing in enterprise and industrial technology startups, particularly those with innovative solutions that address some of the world's most challenging problems. With over two decades of experience, Entrada Ventures is known for its hands-on approach, working closely with founders to navigate critical strategic decisions and solve tactical challenges throughout the lifecycle of their companies. Entrada's investment strategy emphasizes building long-term partnerships with visionary teams, particularly in sectors like AI, quantum computing, cybersecurity, and advanced materials. Their portfolio includes companies like Kipu Quantum, which is pioneering quantum computing for industrial applications, and Coreshell, which focuses on advancing battery technology. The firm prides itself on its deep connection to the Central Coast region but also extends its reach globally, leveraging a network of world-class research ecosystems to drive unique deal flow. Over the years, Entrada has supported numerous startups through various stages, helping them achieve significant milestones, including successful exits and IPOs. Their involvement goes beyond just financial backing, as they actively participate in helping startups connect with prospective teammates, customers, and top-tier follow-on investors.

Entrée Capital, a global venture capital firm founded in 2010, provides multi-stage funding for innovative startups from pre-seed to growth stages. They manage over $1.25 billion across nine funds, focusing heavily on fintech, deep tech, SaaS, AI, blockchain, and e-commerce sectors. Their notable investments include Monday.com, Coupang, Stripe, and Cazoo. Based in Tel Aviv, Israel, with additional offices in London and New York, Entrée Capital primarily targets investments in Israel, the U.S., and Europe. The firm’s strategy involves supporting startups from the idea stage through to scaling, providing both capital and strategic guidance. They actively lead funding rounds and offer extensive mentorship and market insights to help portfolio companies navigate growth challenges. Key team members include Aviad Eyal, co-founder and managing partner, and Eran Bielski, general partner. Both bring extensive experience in venture capital and entrepreneurship, contributing to the firm's strong track record of successful investments and exits. Entrée Capital has backed over 180 startups, achieving more than 27 exits and IPOs, and supporting over 17 unicorns. The firm’s approach emphasizes building strong, long-term relationships with founders and aligning closely with their visions. They are particularly accessible through direct contact on their website and prefer pitches that demonstrate clear, innovative business models and strong market potential.

Entrepreneur First (EF) is a global talent investor founded in 2011 by Alice Bentinck and Matt Clifford. EF's unique approach focuses on helping individuals build technology companies from scratch, often before they have a team or specific idea. This model emphasizes selecting ambitious individuals based on their potential and providing them with the resources to find co-founders and develop their startups. Operating in major cities such as London, Singapore, Berlin, Paris, Bangalore, and Toronto, EF has successfully created over 500 companies with a combined valuation exceeding $10 billion. Some of their most notable investments include Tractable, a computer vision company valued at $1 billion; Magic Pony Technology, which was acquired by Twitter for $150 million; and Omnipresent, a remote HR platform. EF typically invests around £80,000 in each startup in Europe, C$100,000 in Canada, and SG$75,000 in Asia, in exchange for a 10% equity share. Their portfolio boasts significant exits like Deliveroo, PassFort Limited, and Trussle, showcasing their effectiveness in nurturing early-stage startups. EF's investment philosophy prioritizes talent over pre-existing ideas, enabling them to partner with ambitious individuals early in their entrepreneurial journey. The firm has received backing from prominent figures and institutions, including Reid Hoffman, co-founder of LinkedIn, and John and Patrick Collison, co-founders of Stripe. This strong support system, coupled with EF's robust program, helps founders develop their ideas, find co-founders, and secure further investment from top-tier venture capital firms.

Entrepreneurs Roundtable Accelerator (ERA), founded in 2011, is New York City's leading technology accelerator and early-stage venture capital fund. ERA focuses on investing in startups at the forefront of various industries, including health care, financial services, future of work, commerce, and climate. ERA typically invests $150,000 in each company for a 6% stake through a post-money SAFE. The accelerator provides extensive support to its portfolio companies, including free office space, cloud hosting credits, and access to a network of over 1,000 expert mentors. This mentorship network is crucial in helping startups navigate the challenges of early-stage growth. Notable investments by ERA include Glia, TripleLift, Katapult, Thirty Madison, Nayya, Order, Bespoke Post, User Interviews, Fund That Flip, CardFlight, and Scentbird. ERA alumni companies have collectively raised over $2 billion in investor capital and exceed $10 billion in market capitalization. ERA is known for its robust support system, which includes talent acquisition, business development, community and networking, marketing, and PR. The accelerator's commitment to fostering innovation and entrepreneurship has positioned it as a pivotal player in New York's startup ecosystem​.

Envisioning Partners, based in Seoul, South Korea, is a leading impact-focused venture capital firm. Founded to address critical global challenges, the firm targets investments in startups that leverage technology and innovation to tackle climate change, improve health and wellness, enhance education, and transform the future of work. Envisioning Partners manages around $140 million in assets and invests primarily in pre-Series A to Series B stages, supporting companies with both capital and strategic guidance. The firm’s commitment to sustainability and social impact is reflected in its diverse portfolio. Envisioning has backed companies such as Shiok Meats (cell-cultured crustaceans), Mango Materials (biodegradable plastics), and H2 (vanadium redox flow batteries for long-duration energy storage). They have also invested in education and health-related startups like Enuma, which provides accessible learning solutions, and Caring, a platform for elderly care services. Envisioning Partners applies a rigorous impact discipline, aligning its investments with the United Nations Sustainable Development Goals (SDGs). The firm offers robust post-investment support through a global network of advisors and industry experts, helping its portfolio companies achieve both financial success and meaningful social impact​.

EPIC Ventures, based in Salt Lake City, Utah, is a venture capital firm that specializes in early-stage investments in technology sectors such as SaaS, healthcare, security, and fintech. Founded in 1994, EPIC Ventures has a long history of backing companies that are innovating in emerging markets. Some of their notable portfolio companies include Recursion Pharmaceuticals, Medsphere, and Health Catalyst, showcasing their strong focus on health and life sciences. The firm is also active in sectors like future of work and AI, with investments in xAI and Unlearn.AI. EPIC Ventures is known for its hands-on approach, providing not just capital but also strategic guidance and access to an extensive network of advisors. They work closely with the University of Utah through a joint venture called University of Utah Ventures, which focuses on supporting startups and commercialization efforts from academic research.

Epidarex Capital is a dynamic venture capital firm focusing on early-stage life science investments in under-ventured research hubs across the US and UK. The fund targets transformative opportunities in biotechnology, pharmaceuticals, medical devices, and health tech. Notable investments include Dunad Therapeutics, EM Imaging, and Leucid Bio. Established in 2010, Epidarex partners with leading universities and research institutions, providing crucial capital to spin out innovative technologies with the potential for significant patient impact and high financial returns. Their investment strategy prioritizes disruptive platform technologies addressing unmet medical needs, robust intellectual property portfolios, and early evidence of market validation. Epidarex is known for backing driven and tenacious founders, often providing seed or Series A funding. They maintain a rigorous evaluation process to ensure each investment has a sustainable competitive advantage and clear regulatory strategies. Epidarex's team, led by General Partner Elizabeth Roper, boasts extensive experience in the life sciences and venture capital sectors. Roper, with a background at The Wellcome Trust and Atlas Ventures, plays a pivotal role in shaping early-stage opportunities into successful companies. For startups looking to partner with Epidarex, it's crucial to demonstrate strong scientific foundations, clear commercialization pathways, and the potential for outstanding financial returns and patient benefits​.

Episode 1 Ventures, based in London, specializes in early-stage investments in technology companies across the UK. Founded in 2013, the firm focuses primarily on B2B software sectors, including AI, health tech, and software infrastructure. Their portfolio boasts notable investments such as Carwow, Triptease, and AimBrain. Episode 1 Ventures has recently launched a £76 million investment fund to support the next generation of tech startups. This fund is their largest yet and aims to provide substantial support to early-stage B2B firms, reflecting their commitment to fostering innovative UK-based companies​. The firm’s investment strategy typically involves making initial investments ranging from £250,000 to £3 million, guiding startups towards successful Series A rounds. They emphasize a hands-on approach, providing operational expertise and strategic guidance to help startups scale​. Key team members include Simon Murdoch, Adrian Lloyd, and Damien Lane, who bring extensive experience in entrepreneurship and investment. Their combined expertise ensures that Episode 1 Ventures can offer not just financial support, but also valuable mentorship and industry insights to their portfolio companies.

Eppes Creek Ventures is a venture capital firm based in San Francisco, focused on partnering with entrepreneurs and founders to build successful technology companies. Founded in 2016, the firm primarily invests in early-stage and growth-stage startups in the tech sector, with a strong emphasis on innovative solutions. Their portfolio spans across various industries, including real estate, transportation, logistics, and marketing technologies. Eppes Creek Ventures is actively involved in supporting its portfolio companies beyond just funding. It seeks to provide strategic guidance, leveraging its expertise and extensive network to help startups scale effectively. Notable investments include companies like OnePlan, a venue and events management platform, which showcases the firm's commitment to tech-driven solutions in evolving industries. Entrepreneurs looking for early-stage capital and experienced partners can reach out to Eppes Creek Ventures for potential collaboration, especially if their ventures align with the firm’s focus on innovation and high-growth markets.

Epsilon Venture Partners is a stage-agnostic, technology-focused venture capital firm founded in 2015 in Hong Kong by Sudheer Kuppam, who previously served as Managing Director for India and the Asia Pacific region at Intel Capital. The firm invests in technology companies primarily in Asia Pacific and the United States, with countries of investment including Hong Kong, India, and the United States, reflecting Kuppam's deep experience navigating technology markets across both geographies. Epsilon deploys checks of $250,000 to $5 million at Seed and Series A stages across enterprise applications, blockchain technology, business services, enterprise infrastructure, fintech, e-commerce, and health technology. The firm has made 7 investments, with a two-person team led by Kuppam as Managing Partner. The portfolio spans software, fintech, web3, and e-commerce sectors, reflecting a generalist approach within the technology category informed by Intel Capital's broad mandate. Epsilon Venture Partners is listed as inactive. During its operational period the firm applied the corporate venture discipline and network developed at Intel Capital to an independent fund format, seeking to back founders in Asia Pacific and the US who could benefit from Kuppam's two decades of technology investment experience and his relationships across the global semiconductor, enterprise software, and internet sectors that Intel Capital's platform made possible.

EQT Ventures is a powerhouse in the venture capital world, renowned for its robust investment portfolio and strategic prowess. The fund, managing €1.1 billion, focuses on early-stage tech startups, primarily in Europe and North America. Notable investments include Wolt, Peakon, and Airkit, showcasing its knack for backing high-potential companies. EQT Ventures targets industries like fintech, health tech, AI, mobile gaming, and sustainability. The fund is particularly interested in business models with scalable tech solutions that address real-world problems. Geographically, EQT Ventures has a strong presence in Europe and the US, with offices in major hubs like Stockholm, London, Berlin, Paris, and San Francisco. This broad reach helps them tap into diverse markets and innovation ecosystems. Their investment strategy is both aggressive and supportive, offering initial investments ranging from €1 to €50 million. EQT Ventures is known for its active involvement in scaling startups, leveraging a team of over 40 founders and operators. The advisory team, split equally between men and women, uses proprietary AI tools like Motherbrain to identify and nurture high-growth opportunities. Founders can expect a hands-on approach, with EQT Ventures providing not just capital, but also strategic guidance and operational support. The team, led by key figures like Lars Jörnow and Ashley Lundström, brings a wealth of experience and a track record of success in building global companies.

EO Ventures, also known as Equal Opportunity Ventures, is a venture capital firm focused on investing in early-stage businesses that aim to increase economic opportunity in America. Founded by notable figures such as Roland Fryer, a Harvard economist, and Bill Helman, a seasoned venture capitalist, the firm operates with a mission to address stark gaps in opportunity and economic mobility across the country. The firm supports startups that tackle systemic challenges related to racial and economic disparities. EO Ventures provides not only seed funding but also strategic support and access to a world-class team of advisors and researchers, helping entrepreneurs build successful, socially impactful businesses. Their portfolio includes diverse companies like JobGet, Fresh Food Generation, and Forage, which align with their mission of driving significant social change through market-driven solutions. EO Ventures operates with a belief in the power of market forces to expand opportunities, and they specifically target ventures that can have a transformative impact on economic mobility. Their work is further strengthened by partnerships with organizations like the Roxbury Innovation Center, which supports local innovation and entrepreneurship in Boston. The team behind EO Ventures is composed of experts in economics, data science, and venture capital, all united by a commitment to creating measurable social impact through entrepreneurship.

Equitech Ventures is a fintech investment vehicle based in Tel Aviv, Israel, designed to enable financial institutions to participate directly in the Israeli fintech ecosystem. The firm invests at Seed and Series A stages with check sizes ranging from $1 million to $20 million, targeting fintech, AI, and health technology companies primarily focused on the Israeli economy. The structure provides institutional investors with a systematic and structured channel to access Israeli technology companies at early stages. The firm has made 8 investments across fintech, AI and deep tech, and healthtech sectors, deploying an average check of approximately $5 million. Equitech Ventures serves as a bridge between the Israeli startup ecosystem and the financial institutions that seek strategic exposure to innovation in payments, lending, insurance, wealth management, and adjacent financial technology verticals. Equitech Ventures is listed as inactive. During its operational period the firm occupied a distinctive niche as a dedicated vehicle for institutional financial industry investors wanting curated access to Israeli fintech startups, a market that has produced a significant number of globally relevant companies in payments, cybersecurity applied to financial services, and financial data infrastructure. The firm's focus on enabling institutional capital to flow efficiently into early-stage Israeli fintech reflected both the depth of the Israeli technology ecosystem and the growing appetite of incumbent financial institutions to engage with startup innovation.

Esco Ventures, the investment arm of Singapore-based Esco Group, focuses on early-stage life sciences and medtech startups. The firm specializes in areas like biotech, diagnostics, and women’s health, aiming to nurture groundbreaking technologies that improve global health. What sets Esco Ventures apart is its hands-on approach, offering startups more than capital by providing mentoring, productization, manufacturing support, and global distribution networks through its parent company, Esco Group. Esco Ventures plays a crucial role in shaping the next wave of medical innovations, drawing on Esco Group’s decades of experience in life sciences. Their investment philosophy is built around long-term growth, with an emphasis on addressing unmet medical needs through disruptive technologies. The firm has a global reach but maintains a particular focus on Singapore, aligning with the nation’s vision to become a biomedical innovation hub in Asia. Under the leadership of Managing Partner XiangQian Lin, Esco Ventures works closely with scientists, engineers, and entrepreneurs, guiding them from ideation to commercialization. The firm has already seen success with investments like a Danish/Lithuanian medical device company, which achieved 5x growth within three years. Esco Ventures also actively supports the local Singaporean ecosystem by mentoring early-stage researchers and startups even before formal incorporation, fostering a collaborative and innovative environment aimed at creating the next big breakthroughs in life sciences and medtech.

Espalier Ventures is a single-family office and venturing organization founded in 2003 in Brighton, United Kingdom, by entrepreneur Andrew Colin. The firm maintains a growing portfolio of businesses and investments concentrated in education, wellbeing, and real estate. Colin brings a 30-year history of founding, funding, and leading innovative international education projects, and Espalier reflects his continued conviction in these sectors as an investor and company builder. The firm's principal education business is INTO University Partnerships, the global leader in international student recruitment and education, which operates under a unique joint venture model with 23 universities in the United States and the United Kingdom. Outside of INTO, Espalier runs an early-stage venturing arm that invests in and builds its own education, wellbeing, and workforce businesses. The 9-company portfolio spans education, healthtech and wellness, real estate and proptech, and HR and recruitment, with investments across the UK, United States, and other markets. Check sizes range from $500,000 to $5 million at Seed and Series A stages. Espalier also invests across a broader asset base including public and private debt, equity investments, real estate, and alternative investments. The organization's tight thematic focus on education, wellbeing, and workforce, combined with the operational experience embedded in the INTO University Partnerships business, gives Espalier a distinctive vantage point for evaluating and supporting new ventures in adjacent spaces.

ET Capital, established in 1992, is a distinguished venture capital firm based in southern England, with a particular focus on the dynamic tech ecosystems around Cambridge, Oxford, and London. The firm has raised and managed a series of funds aimed at high-growth technology businesses within these globally significant clusters. Initially backed by HSBC and the European Investment Fund, ET Capital has since evolved into a key player in the UK’s venture capital landscape, particularly in the realms of life sciences, information technology, and green technology. The firm has a robust portfolio of over 40 companies, with notable successes like ADC Therapeutics, a biotech company that went public on the NYSE in 2020 with a valuation of $1.3 billion. ET Capital also plays a pivotal role in the climate tech space through its management of the Carbon13 SEIS Funds, which invest in startups dedicated to addressing the climate emergency. These funds are closely linked to the Carbon13 venture builder, a Cambridge-based initiative that fosters innovative companies focused on significant carbon emission reductions. Led by Managing Director Martin Rigby, who brings over 30 years of experience in early-stage technology investments, ET Capital is known for its deep expertise in nurturing innovative tech companies from inception to success. The firm’s investment strategy is characterized by a strong emphasis on early-stage, science-based businesses with the potential to scale globally. ET Capital’s partnerships extend internationally, including ventures like the UK China Enterprise, which supports science-based businesses aiming to expand into the Chinese market​.

EthAum Venture Partners is a deep technology revenue scaler, incubator, and accelerator founded in 2018 and headquartered in Singapore, with team members operating across the United States, India, and more than seven additional locations globally. The firm runs the Zero BS Revenue Scaler Program, a structured engagement that helps post-revenue B2B startups acquire customers, strategic partners, and investors, with guaranteed measurable results. EthAum has built a portfolio of over 100 startups from Seed to Series B stage, collectively serving Fortune 1000 organizations worldwide. The firm has made 54 recorded investments across AI and deep tech, SaaS, healthtech, software, B2B enterprise technology, hardware, and security sectors, deploying checks of up to $2 million with partner funds. Notable portfolio companies include The Wedding Company and Cybord. The team of 25 includes 4 partners, 10 venture partners, and 2 principals, creating a large ecosystem of experienced operators who engage directly with portfolio companies on revenue and commercial development. EthAum Venture Partners distinguishes itself through its operational focus rather than purely financial investment, working intensively with founders on go-to-market execution, enterprise sales, and partnership development. The firm concentrates on companies targeting Fortune 1000 customers, leveraging its global team and extensive corporate network to open doors that early-stage B2B companies cannot easily open independently. This execution-focused model positions EthAum at the intersection of venture capital and management consulting.

Ethias Ventures is the corporate venture capital arm of Ethias Group, Belgium's largest direct insurer with 1.2 million B2C customers and 46,500 B2B customers and a Fitch rating of A. Founded in 2022 and headquartered in Liege, Belgium, the firm invests equity or provides loans to startups delivering innovative solutions with demonstrated societal value. The investment thesis targets European startups in insurtech, mobility, health, and property that have a visible link to the insurance value chain, whether in underwriting, claims processing, or product innovation, and that show tangible commercial traction. Ethias Ventures deploys checks of $1 million to $3 million at Seed and Series A stages across 12 European countries including Belgium, France, Germany, the United Kingdom, the Netherlands, and the Nordic markets. The firm has made 7 investments across fintech and insurance technology, healthtech, mobility, and clean energy. Notable portfolio companies include moveUP in health technology, Linkbycar in connected vehicle services, and Power Capital Renewable Energy. As the investment arm of a major Belgian insurer, Ethias Ventures brings more than capital to its portfolio companies. The firm leverages Ethias Group's large and established customer base, distribution channels, and regulatory relationships to help insurtech and adjacent startups access a substantial built-in market and validate their products in real-world insurance and financial services environments. This strategic connection to a major incumbent insurer is the firm's primary value-add beyond the investment check itself.

Eudemian Ventures is a Silicon Valley-based VC firm founded in 2018, with a transatlantic reach, focusing on early-stage software startups in the US. Their key sectors include SaaS, AI, fintech, digital health, marketplaces, and edtech. Notable investments span innovative companies such as Brave Care, GRIN, Deep Sentinel, and Apty. They emphasize investing in bold founders who demonstrate the potential for scaling to global markets, and their portfolio boasts a strong commitment to diversity, with over 60% of their companies having diverse founders. Their strategy revolves around leading Seed and Series A rounds, offering not just capital but also operational expertise and a global network to help startups achieve product-market fit. Their average check size varies, though they have raised a $10 million maiden fund aimed at nurturing early-stage ventures. Recent investments like Efficient Capital Labs highlight their interest in cutting-edge fintech solutions. They have a hands-on approach, often staying with companies through multiple funding cycles. The firm is led by founder Raoul Felix Maier, based in San Francisco, supported by a globally diverse team with deep expertise in entrepreneurship, venture capital, and management consulting. Eudemian Ventures is selective, actively curating their pipeline through both inbound inquiries and their extensive industry connections.

Eurazeo is a prominent global investment group with approximately €35 billion in assets under management, including €24 billion managed on behalf of institutional and private clients. The firm specializes in private equity, private debt, and real assets, with investments spanning consumer, healthcare, tech-enabled services, and financial services sectors. Notable investments include high-profile companies like Moncler, Farfetch, Vestiaire Collective, Asmodee, and Orolia, as well as tech companies like Deezer and Onfido. Eurazeo’s strategy focuses on identifying and accelerating the growth potential of their portfolio companies through capital investment and strategic support. Eurazeo operates across various investment strategies, including buyouts, growth capital, venture capital, and real assets. With offices in Europe, North America, and Asia, Eurazeo has a diverse geographic reach and is committed to long-term value creation with a responsible investment approach.

Eureka! Venture SGR, established in 2019, is Italy's first independent venture capital firm focusing exclusively on deep tech investments. Based in Milan and Rome, Eureka! specializes in transformative technologies, including AI, energy, health and well-being, mobility, and environmental innovations. The firm manages Eureka! Fund I, a technology transfer fund designed to bridge the gap between scientific discovery and commercial success. With a focus on startups born from cutting-edge research, Eureka! aims to foster the development of deep tech solutions that have the potential to revolutionize industries. Their portfolio includes startups like BeDimensional (nanotechnology) and ReHouseIt (sustainable construction), reflecting their commitment to impactful innovation. Eureka! also adheres to strict ESG (Environmental, Social, Governance) principles, aligning their investments with the UN's 2030 Sustainable Development Goals. The firm’s leadership, including CEO Stefano Peroncini and co-founder Anna Amati, brings over 25 years of experience in venture investing and technology transfer. This expertise enables them to guide startups from initial innovation to market, leveraging strategic partnerships with universities and research institutions across Europe. In addition to deep tech, Eureka! operates the BlackSheep Fund, which invests in late-stage European tech companies transforming the marketing industry through AI and big data.

The European Circular Bioeconomy Fund (ECBF) is a specialized venture capital fund dedicated to driving the transition from a fossil-based to a bio-based economy in Europe. Established in 2020 and headquartered in Luxembourg, ECBF was initiated with support from the European Union to fill a critical funding gap identified in the growth phase of bioeconomy companies. The fund, managed by Hauck & Aufhäuser Funds Services S.A. and advised by ECBF Management GmbH, has raised €300 million, surpassing its initial target of €250 million. ECBF focuses on investing in growth-stage companies that contribute to the circular bioeconomy, aiming to support innovative entrepreneurs whose technologies can revolutionize industries and promote sustainability. The fund's portfolio includes companies across various sectors such as bio-based materials, agritech, and bioplastics. ECBF's investments align with the European Green Deal goals, particularly the aim to make Europe climate neutral by 2050. The fund's approach combines financial support with strategic guidance, leveraging a diverse and experienced team to help portfolio companies achieve both environmental impact and favorable financial returns. Investors in ECBF include a mix of public and private entities from across Europe, reflecting broad support for advancing the bioeconomy sector.

EV Private Equity is a Norwegian venture capital firm dedicated to decarbonizing the energy sector through strategic investments in cutting-edge energy technology companies. With offices in Stavanger, Norway, and Aberdeen, UK, EV Private Equity manages a robust portfolio of 16 companies across Europe and North America. They focus on high-growth, technology-driven firms that demonstrate substantial potential for reducing greenhouse gas emissions and improving energy efficiency. Their investment strategy targets companies in the growth stage with experienced management teams, scalable business models, and differentiated technology offerings. EV Private Equity has committed to a significant environmental impact, aiming to remove one tonne of CO2e for every €300 invested. This rigorous approach is backed by third-party assessments of their impact achievements, ensuring transparency and accountability. Notable investments include Bluware, a leader in seismic data interpretation, and Trainor Group, a digital electrical safety training provider. Both companies have seen substantial growth under EV Private Equity's guidance, culminating in successful exits to larger strategic acquirers. Key team members, such as Senior Partner Rune Jensen, bring extensive industry experience and leadership, fostering a culture of innovation and sustainability. Startups seeking investment should demonstrate strong environmental impact potential and a clear path to scalable growth. EV Private Equity prefers to be approached with detailed, impact-oriented proposals that align with their mission of driving the energy transition.

Evening Fund is a venture capital firm based in Mountain View, California, founded in 2021. The firm focuses on early-stage investments, particularly in the Seed, Series A, and Series B stages, targeting sectors such as artificial intelligence and machine learning (AI/ML), fintech, and cloud technology. Notable investments by Evening Fund include Flyby Robotics, an end-to-end drone automation and delivery company; Byteboard, a platform providing technical interview solutions for hiring engineers; and Reworth, a fintech company based in Mexico. Other significant investments include Akudo, a financial services startup aimed at helping teenagers build credit, and Connectly.ai, a messaging platform for businesses. The fund is known for its approach of combining traditional venture capital practices with the unique insights and expertise of its founders, who are full-time entrepreneurs and evening investors. This blend provides their portfolio companies with both financial support and strategic guidance to help them grow and succeed in competitive markets.

Everest Venture Capital, also known as Lang Ma Feng Venture Capital, is a Beijing-based early-stage venture capital fund founded in 2007, with offices in both Beijing and Shenzhen covering investments across mainland China. The firm operates with a team of 140 employees bringing rich industrial experience to Chinese technology company formation and growth. Everest has made 172 investments with 24 portfolio exits, establishing itself as one of China's most active early-stage investors across multiple technology cycles. The firm deploys $1 million to $10 million checks at Seed, Series A, and Series B stages, with a focus on technology companies across software, AI and deep tech, healthtech, consumer electronics, e-commerce, hardware and robotics, fintech, data analytics, and education. In 2018, Everest Venture Capital was recognized among the top 10 most active private equity investment institutions and the top 50 best venture capital institutions in China, reflecting both the volume and quality of its investment activity. Everest Venture Capital operates with a concentrated focus on the Chinese domestic technology market, leveraging its large team and deep local networks across Beijing and Shenzhen to source and support early-stage founders at scale. The firm's depth across a broad range of Chinese technology verticals gives it the pattern recognition to identify promising companies in a competitive and rapidly evolving market where local expertise and relationships are critical competitive advantages for investors and portfolio companies alike.

Evergreen Venture Partners is one of Israel's first venture capital firms, founded in 1987 in Tel Aviv with $650 million in venture capital funds under management. Over nearly four decades, the firm invested in more than 120 technology companies, representing one of the largest VC portfolios built in Israel. Evergreen specializes in early-stage and emerging growth companies in communications, internet and media, software, and healthcare, investing across Israel and the United States and leading rounds with checks typically around $10 million. The firm invested at Series A, Series B, and Series C stages, with a focus on companies requiring $3 million to $10 million in institutional capital. Notable portfolio companies include Taboola, the content discovery platform that went public on the Nasdaq, Quali in cloud infrastructure automation, and Siklu in millimeter-wave wireless communication technology. The broader portfolio of 120-plus investments spans software, communications, healthtech, AI and deep tech, hardware, fintech, media, and security. Evegreen Venture Partners built its reputation on a professional investment team with deep field expertise in technology markets, guiding entrepreneurs through the full company lifecycle from early development through liquidity events. The firm's technical, operational, and strategic support model was developed across decades of Israeli technology company building and reflected a hands-on partnership philosophy. Evergreen Venture Partners is now inactive, though its long track record and portfolio of significant Israeli technology companies remains a defining part of the country's venture history.

Everywhere Ventures is a global pre-seed venture capital fund founded in 2018 in New York by Jenny Fielding and Scott Hartley. What began as a modest New York City-focused side project has grown into a global operation with over $100 million in assets under management and more than 505 investments across a diverse international portfolio. The fund draws nearly all of its capital from over 500 founder and operator limited partners, creating an LP base that doubles as a network of experienced builders who actively support portfolio companies. Everywhere invests in pre-seed deals globally, typically entering in the first financing round with checks of $25,000 to $100,000. Investment emphasis falls on purpose-driven teams building across money, health, and work verticals, with coverage spanning fintech, healthtech, SaaS, B2B, AI, software, e-commerce, clean technology, HR, and education. The geographic reach includes the United States, United Kingdom, Germany, France, Australia, and Spain. The firm also prioritizes high-performing women-led companies addressing global challenges in health, climate, and prosperity, applying a proprietary bias-eliminating selection process. Fielding and Hartley built Everywhere on the conviction that founders who have themselves built successful companies are best positioned to advise and support early-stage startups. The firm's founder-LP model ensures that every company in the portfolio has access to a community of 500-plus operators with direct experience in scaling businesses, creating a support network that is as valuable as the initial check at the pre-seed stage.

Evig Alfa, based in Poznan, Poland, is a prominent venture capital fund focused on early-stage technology projects. Founded in partnership with Carlson Ventures International Ltd., the fund targets sectors like AI, FinTech, MedTech, IoT, and CleanTech. Notable investments include AI Seller, Connect4Kids, and True Moves, showcasing their commitment to innovative R&D projects with global commercialization potential. Evig Alfa typically invests up to PLN 1.1 million per project, focusing on the Proof of Concept (PoC) and Proof of Principle (PoP) stages. They prioritize projects rooted in the Polish academic environment, ensuring that at least 80% of funds are dedicated to R&D activities. Key team members include Dawid Wesołowski, CEO, who emphasizes a hands-on approach to guiding startups through their growth phases. The fund's strategy involves a 4-5 year investment horizon, aiming to nurture projects until they achieve significant technological readiness and market impact. Evig Alfa is highly active, with an average of nearly ten investments per year, and their approach to collaboration and innovation makes them a vital player in the European VC landscape. Startups looking to approach Evig Alfa should emphasize their R&D capabilities and the potential for scalable innovation in line with the fund’s focus areas.

Evio Venture Capital is an early-stage venture capital firm founded around 2020, with a team based in Singapore and Greece, focused on mental health, wellness, education technology, and the future of work. The firm invests in companies building in mental health, personal growth, and adult education at Seed and Series A stages with checks of $100,000 to $1 million. Despite a small portfolio of 7 companies, Evio has achieved a remarkable concentration of high-value outcomes. The firm's portfolio includes two unicorns: BetterUp, a professional coaching and mental health platform valued at $4.7 billion, and Calm, a meditation and sleep application valued at $2 billion. An additional notable investment is MyDoc, a telemedicine platform. The team of four includes two partners. These outcomes reflect an early and conviction-driven view of the mental health technology market at a time when the sector's commercial potential was not yet widely recognized by mainstream venture capital. Evio represents a specialized thesis in the growing mental health and wellness technology sector, investing ahead of broad consumer and enterprise adoption of digital mental health tools. The firm's concentration on Seed and Series A investments in a tightly defined vertical enabled it to build deep expertise and relationships within the mental health technology ecosystem. The outsized results in BetterUp and Calm validate the firm's thesis that mental health and personal development represent a durable and structurally important category for technology investment.

Evli Growth Partners (EGP) is a Helsinki-based venture capital firm that focuses on late-stage investments across Europe. Founded in 2018 as part of Evli Asset Management, EGP operates two funds: EGP I with €60 million in commitments and EGP II with €76 million. The firm targets investments ranging from €3 to €5 million, supporting high-growth companies that demonstrate strong revenue and sustainable business models. EGP's investments span sectors such as technology, sustainability, and consumer goods. EGP is driven by a commitment to impact investing, integrating sustainability into every investment decision. The firm actively promotes climate change mitigation by supporting portfolio companies with carbon emission reduction strategies and by aligning with Evli’s goal of achieving carbon neutrality by 2050. EGP excludes sectors with high carbon footprints or social costs, focusing instead on businesses that demonstrate responsible governance and positive environmental impacts. Notable investments include Refurbed, which aims to cut electronics emissions by 70%, and Tylko, a company transforming the furniture industry through sustainable design and production. With a diverse portfolio and a clear focus on sustainability, EGP continues to back entrepreneurial ventures that not only deliver strong financial returns but also contribute positively to society and the environment​.

Evolution VC Partners is a New York-based venture capital firm focused on "culture-tech" investments—companies that are reshaping how people work, live, and interact with technology. Established by Gregg Smith, the firm primarily invests in sectors such as advanced materials, 3D printing, fintech, media, entertainment, digital health, life sciences, and plant-based innovations. Their goal is to support disruptive companies that are defining today's culture and paving the way for future societal shifts. The firm is stage-agnostic, meaning it invests in companies at various phases, from early-stage to growth-stage ventures. Evolution VC Partners works closely with founders, providing not just capital but also strategic advice to accelerate growth. Their portfolio includes notable companies like Instacart, Rodo, DailyPay, and Axiom Space. What sets Evolution apart is that it operates solely with the founder's personal capital, allowing for more flexibility and focus on long-term impact rather than external fund performance​.

Evolv Ventures is a venture capital firm based in Chicago, founded in 2018 by Kraft Heinz with a $100 million fund to invest in emerging technologies that are transforming the food industry. The fund is particularly focused on early-stage startups in sectors like food technology, retail technology, consumer products, and digital logistics. Evolv Ventures leverages Kraft Heinz’s extensive network, industry expertise, and resources to support the growth of its portfolio companies, positioning itself as a value-added investor in the food tech space. The firm is led by seasoned venture investor Bill Pescatello, who brings a wealth of experience from previous roles at Lightbank and GE Capital. Notable investments by Evolv Ventures include companies like New Culture, which is developing animal-free dairy products, and Zippin, a startup focused on checkout-free retail technology. By combining financial backing with strategic support, Evolv Ventures aims to drive significant innovation and disruption within the food industry, ultimately aligning with Kraft Heinz’s broader goals of staying at the forefront of food innovation.

Evonik Venture Capital, the corporate venture arm of Evonik Industries, manages a fund size of €400 million and has made over 50 investments since 2012. The firm strategically invests in innovative startups across various growth fields such as Nutrition & Care, Smart Materials, Specialty Additives, and Digitalization, with a strong focus on sustainability and carbon neutrality technologies​. Evonik's portfolio includes startups like Interface Polymers, which develops additives for easier recycling of plastics, and SuperC, a leader in graphene materials for improving lithium-ion batteries. Other notable investments are Allay Therapeutics, which has developed a post-surgery pain relief implant, and Citrine Informatics, an AI-driven platform for materials and chemicals development​. The venture capital unit emphasizes early to growth-stage investments, with typical investment volumes of up to €15 million per portfolio company. They aim to be an active partner, providing strategic, technical, and commercial support, and leveraging their extensive network for the growth of their portfolio companies. Evonik Venture Capital operates globally with offices in Germany, the USA, and China, making them well-positioned to support innovative startups in key regions worldwide.

Excalibur Group Holdings, based in London, is a venture capital firm with a strong focus on life sciences, biotechnology, and medical devices. Established in 1996, the firm has built a reputation for bridging the gap between research and commercialization, providing both early and late-stage capital. Excalibur plays an active role in developing cutting-edge therapies, diagnostics, and healthcare technologies. Their investment strategy targets companies that are innovating in critical areas such as oncology, therapeutic devices, and laboratory services. The firm has made over 59 investments, with notable companies like Celsis International, NeoGen, and Selah Genomics. Excalibur's investments span various stages, from early ventures to generating revenue, and their portfolio emphasizes transformative healthcare solutions. They have also facilitated numerous successful exits, including companies like Plethora Solutions and Celsis In Vitro. Excalibur's approach is highly strategic, supporting startups not just with capital but also by offering market access and strategic advice, positioning them for acquisitions or public listings. This makes Excalibur a critical player in the European life sciences venture space, known for its ability to take healthcare innovations from the lab to the marketplace.

Excel Venture Management, founded in 2007 and headquartered in Boston, Massachusetts, specializes in investing in transformative life science technologies. The firm’s portfolio spans healthcare IT, diagnostics, medical devices, and life science platforms, addressing a broad array of industries including agriculture, energy, and defense. Notable investments include InfoBionic, Aileron Therapeutics, and Molecular Templates. Excel's strategy focuses on early to late-stage investments, typically ranging from $1 million to $5 million. They avoid single-molecule drugs, preferring platform technologies that offer multiple exit scenarios and applications across diverse market sectors. The firm's holistic approach involves extensive due diligence, strategic guidance, and leveraging a global network of resources to drive portfolio companies towards leadership positions in their fields. The team, led by key figures like Jeanne Henry (CFO) and Juan Enriquez (Managing Director), brings a wealth of experience in venture capital, financial management, and life sciences. They work closely with entrepreneurs to refine corporate strategies, develop value-driven milestones, and facilitate customer and partner introductions, ultimately aiming for successful exits through acquisitions or IPOs. Excel Venture Management has been instrumental in the success of companies like ClearDATA, Cleveland HeartLab, and Synthetic Genomics, showcasing their commitment to driving innovation in the life sciences sector and beyond​.

Excell Partners is a prominent venture capital firm based in Rochester, New York. Established in 2006, it focuses on seed-stage investments, primarily targeting high-tech, high-growth startups in Upstate New York. Excell Partners is an affiliate of the University of Rochester and manages over $40 million in assets, having invested in 60 companies across various sectors including medical devices, materials, energy, biotech, agtech, imaging, and IT/software. Under the leadership of CEO Theresa Mazzullo, Excell Partners emphasizes a hands-on approach, providing not only capital but also extensive support through strategic guidance, a broad network of professionals, and long-term partnership commitments. Their investment strategy includes maintaining "dry powder" for follow-on funding to ensure continuous support for portfolio companies as they scale. Excell Partners also manages the $25 million Finger Lakes Forward Venture Capital Fund, which supports regional strengths in optics, imaging, photonics, food and agriculture, life sciences, and advanced manufacturing. This fund aims to boost economic growth in the Greater Rochester area by increasing access to capital for high-tech startups. Notable investments include RealEats, a prepared meal delivery service, and Owl Autonomous Imaging, which focuses on advanced thermal sensor technologies. Excell Partners is dedicated to fostering innovation and economic development in the Finger Lakes region, leveraging the area's academic and research strengths to nurture promising startups and retain local talent.

Exceptional Ventures is a London-based venture capital firm focused on investing in high-impact startups that aim to improve health, happiness, and longevity while also supporting a sustainable planetary ecosystem. Founded by Matt Cooper and Paolo Pio, the firm manages its debut fund, EV Fund 1, which is a £20 million fund designed to build a portfolio of 40 early-stage startups primarily across the UK and Europe, with some investments globally. The firm invests primarily in three sectors: HealthTech, FoodTech, and Financial Wellbeing. Their strategy is to back startups at the pre-seed and seed stages, with the potential to follow on with additional funding as these companies grow and approach Series A. Exceptional Ventures' portfolio is expected to span a variety of innovative companies within these sectors, supporting technological advancements that contribute to a healthier and more sustainable future. The founders bring extensive experience in venture capital and entrepreneurship. Matt Cooper co-founded Capital One Bank and has chaired Octopus Group, while Paolo Pio has a strong background in tech and venture capital, having previously led Joyance Partners in Europe.

Exfinity Venture Partners is an early-stage venture capital firm founded in 2013 in Bengaluru, India, focused exclusively on backing B2B technology companies built from India for global markets. The firm was promoted by four veterans of the Indian IT industry: Mohandas Pai and V Balakrishnan, both former CFOs of Infosys; Girish Paranjpe, former CEO of Wipro; and Deepak Ghaisas, former CEO of iflex. With a portfolio of more than 40 companies, Exfinity has backed founders across AI and machine learning, cybersecurity, autonomous robotics, AI cancer diagnostics, EV and mobility, computer vision, IoT, big data and analytics, and cloud computing. The firm leads rounds and deploys initial checks typically between $500K and $3 million, with maximum deal sizes reaching $5 million, investing primarily at Seed and Series A stages. The portfolio includes one unicorn, Cult.fit, and seven acquisitions including Locus and Ai Palette. Exfinity targets founders who are building disruptive, innovative technology products with a clear global ambition rooted in India. Exfinity differentiates itself through a world-class mentorship ecosystem built from the operational credibility of its founding team. The promoters bring direct experience scaling multi-billion-dollar IT enterprises and leverage those networks to help portfolio companies navigate enterprise sales, international expansion, and follow-on fundraising. The firm is deeply committed to the Indian B2B deep tech thesis, treating mentorship and financial capital as equally important inputs for company building.

Exor N.V. is a prominent European investment company headquartered in Amsterdam, Netherlands, controlled by the Agnelli family. Established in 1927, Exor's portfolio is diverse, encompassing various industries such as automotive, luxury goods, media, and healthcare. Key holdings include significant stakes in well-known companies such as Ferrari, Stellantis, and CNH Industrial. Exor owns 22.9% of Ferrari, making it a crucial player in the luxury sports car market. Stellantis, one of the world's leading automakers, also forms a significant part of their portfolio with brands like Fiat, Chrysler, and Peugeot. CNH Industrial, involved in agricultural and construction equipment, is another major investment. In the media sector, Exor holds a substantial share in The Economist Group, owning 43.4% of its economic rights. They also have a significant investment in GEDI Gruppo Editoriale, a major Italian media conglomerate, holding 89.6% of the economic rights. Exor's investment strategy focuses on long-term value creation, often involving active participation in the management of their portfolio companies to drive growth and innovation. This approach is evident in their diversified and strategically selected investments across various sectors.

Expa, founded by Garrett Camp in 2013, is a venture studio and VC fund based in San Francisco. It focuses on early-stage investments, particularly in SaaS, FinTech, ClimateTech, E-Commerce, and software sectors. Notable investments include companies like Aero, Current, Collective, Metabase, and Joro. With over 100 investments and 11 exits, Expa typically provides seed funding between $500K and $1M and plays an active role in guiding startups through MVP development, hiring, and finding product-market fit. Expa’s strategy is centered around supporting founders with both capital and hands-on expertise. They value strong, innovative ideas and prefer to be approached with detailed, well-structured pitches demonstrating clear market potential. Their global reach includes significant investments across the U.S., with key operations in San Francisco​​. The Expa team, featuring industry leaders and experienced entrepreneurs, ensures robust support for their portfolio companies. For those looking to engage with Expa, networking through industry events and leveraging mutual connections can be effective ways to gain their attention.

Expansion Venture Capital, also known as Expansion VC, is a prominent early-stage venture capital firm focused on investing in pre-seed, seed, and select Series A stage technology companies. Founded by brothers Joseph and Ryan Melohn, the firm operates primarily out of New York City and Miami. Expansion VC's portfolio boasts a range of successful companies across various sectors, including notable investments in ClassPass, Turo, Carta, Lemonade, The RealReal, Allbirds, and Firebase. These investments span industries such as fintech, proptech, digital health, and consumer technology. The firm is known for its hands-on approach, providing not just capital but also strategic support in areas like mentorship, customer acquisition, talent sourcing, and securing partnerships. The firm prides itself on building long-term relationships with its founders, offering around-the-clock support to help navigate challenges and drive growth. Expansion VC has a reputation for leveraging its extensive network to accelerate the success of its portfolio companies by facilitating key introductions and securing strategic guidance.

Expedite Ventures is a Berlin-based business angel group founded in 2020, composed of active and former CTOs and CPOs who invest their own capital in early-stage technology founders. The group backs pre-seed and seed stage startups, writing checks between $100K and $500K, with occasional participation at Series A. Expedite has made 11 investments spanning SaaS, software, AI, fintech, and healthtech, with a geographic focus on Germany and the United States. The firm's core thesis centers on software categories that drive creation and transformation, including SaaS, developer tools, and productivity tools. Members are described as nerds at heart, with several partners still actively running their own startups while investing. This practical orientation shapes how Expedite engages with portfolio companies: support is hands-on and technically grounded, covering product architecture, team building, and go-to-market alongside capital. Expedite specifically welcomes first-time founders and does not filter by gender or background, prioritizing intellectual rigor and product conviction over pedigree. The group's structure as an angel collective means each member brings direct operational context from running technology businesses, giving portfolio companies access to a bench of seasoned product and engineering leaders who understand the challenges of early-stage company building from the inside.